Healthcare Services

Bacterial Vaginosis Market to Reach $5.12B by 2030 with Steady Growth

April 17, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Bacterial Vaginosis Market Projected To Reach By 2030?

The market size for bacterial vaginosis has shown considerable growth in recent years. It is projected to expand from $3.31 billion in 2025 to $3.62 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.4%. Its historical expansion is primarily due to factors such as the increasing prevalence of bacterial vaginosis among women, greater access to gynecological healthcare services, the availability of oral and topical antibiotics, the expansion of diagnostic laboratory services, and growing clinical screening initiatives.

The bacterial vaginosis market is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $5.13 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.1%. Factors driving this growth during the forecast period include the escalating development of microbiome-based therapies, wider adoption of rapid molecular diagnostics, a heightened emphasis on preventive women’s health, the broadening of telehealth-supported diagnosis, and increased investment in non-antibiotic treatment options. Key trends anticipated for the forecast period encompass a surge in the adoption of point-of-care diagnostic tests, an increasing demand for targeted antibiotic therapies, heightened awareness regarding vaginal microbiome health, the expansion of home-based testing solutions, and an intensified focus on early detection and screening.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/bacterial-vaginosis-global-market-report

Which Major Drivers Are Influencing The Expansion Of The Bacterial Vaginosis Market?

The bacterial vaginosis market is anticipated to expand due to the rising occurrence of sexually transmitted infections (STIs). STIs are defined as infections predominantly transmitted through sexual activity, which can originate from bacteria, viruses, or parasites. The heightened frequency of STIs stems from elements such as unprotected sexual intercourse, having multiple partners, insufficient public awareness, and the development of antibiotic resistance. Bacterial vaginosis heightens vulnerability to STIs by disturbing the natural bacterial equilibrium in the vagina, thereby facilitating the establishment of infections like HIV and chlamydia. For example, data from the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, shows that gonorrhea cases increased from 70,881 in 2022 (17.9 per 100,000) to 96,969 in 2023 (25.0 per 100,000), representing a 31% year-on-year increase. Concurrently, syphilis cases ascended from 35,391 in 2022 (8.5 per 100,000) to 41,051 in 2023 (9.9 per 100,000), marking a 13% increase. Furthermore, chlamydia notifications totaled 230,199 in 2023, which signifies a 3% rise in the crude notification rate when compared to 2022. Consequently, the escalating occurrence of sexually transmitted infections (STIs) is fueling the expansion of the bacterial vaginosis market.

Which Segments Define The Bacterial Vaginosis Market Segment Structure?

The bacterial vaginosis market covered in this report is segmented –

1) By Type: Point-Of-Care Testing, Laboratory Testing

2) By Application: Diagnosis, Treatment, Recurrence Prevention Or Maintenance, Screening And Monitoring

3) By End-User: Hospitals, Homecare, Specialty Clinics

Subsegments:

1) By Point-Of-Care Testing: Rapid Diagnostic Tests, Microscopy-based Tests

2) By Laboratory Testing: Gram Staining, Polymerase Chain Reaction (PCR), DNA Probe Tests

Which Trends Are Shaping The Bacterial Vaginosis Market?

Major companies operating in the bacterial vaginosis market are focusing on developing novel solutions, such as paired prescription regimens for sexual partners, to achieve a competitive edge. These paired prescription regimens entail prescribing treatment not only to the infected individual but also to their sexual partner, thereby tackling recurrence risk at its source. For example, in March 2025, Wisp, a U.S.-based women’s telehealth company, launched the first-ever Male BV Partner Treatment, which is a two-part prescription regimen composed of oral metronidazole and topical clindamycin specifically for male partners. It incorporates synchronized dual treatment, once-daily administration for seven days, and delivery through Wisp’s telemedicine platform. This strategy leverages emerging clinical evidence to lower reinfection rates and reinforces the shift towards more holistic, relationship-conscious care, despite potentially increasing regulatory complexity and raising questions about partner compliance.

Who Are The Established Players Within The Bacterial Vaginosis Market?

Major companies operating in the bacterial vaginosis market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., Viatris Inc., Organon & Co., Shionogi & Company Limited, Otsuka Pharmaceutical Co. Ltd., Melinta Therapeutics Inc., Evofem Biosciences Inc., Gedea Biotech AB, Hologic Inc., bioMérieux SA, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Roche Holding AG, Abbott Laboratories, Ferring Pharmaceuticals, Mylan N.V., Almirall S.A.

Get The Full Bacterial Vaginosis Market Report:

https://www.thebusinessresearchcompany.com/report/bacterial-vaginosis-global-market-report

Which Region Represents The Largest Share Of The Bacterial Vaginosis Market?

North America was the largest region in the bacterial vaginosis market in 2025. The regions covered in the bacterial vaginosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Bacterial Vaginosis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/bacterial-vaginosis-global-market-report

Browse Through More Reports Similar to the Global Bacterial Vaginosis Market 2026, By The Business Research Company

Vaginal Speculum Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaginal-speculum-global-market-report

Bactericide Market Report 2026

https://www.thebusinessresearchcompany.com/report/bactericide-global-market-report

Acute Bacterial Skin And Skin Structure Infections Market Report 2026

https://www.thebusinessresearchcompany.com/report/acute-bacterial-skin-and-skin-structure-infections-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795